Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial

Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities

(2013) Djordje Miljković et al.   ANTIOXIDANTS & REDOX SIGNALING

Elevation of Tumor Necrosis Factor Alpha in Dorsal Root Ganglia and Spinal Cord is Associated with Neuroimmune Modulation of Pain in an Animal Model of Multiple Sclerosis

(2013) F. Begum et al.   Journal of Neuroimmune Pharmacology

The Immune Pathogenesis of Multiple Sclerosis

(2013) Robert Weissert   Journal of Neuroimmune Pharmacology

Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation

(2013) Slava Rom et al.   Journal of Neuroimmune Pharmacology

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Gabapentin Enacarbil in Subjects With Neuropathic Pain Associated With Postherpetic Neuralgia (PXN110748)

(2013) Lixin Zhang et al.   JOURNAL OF PAIN

Combined carbamazepine and pregabalin therapy in a rat model of neuropathic pain

(2012) T.S. Hahm et al.   BRITISH JOURNAL OF ANAESTHESIA

A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis

(2012) R. M. Langford et al.   JOURNAL OF NEUROLOGY

MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial

(2012) John Peter Zajicek et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Probable involvement of Ca2+-activated Cl− channels (CaCCs) in the activation of CB1 cannabinoid receptors

(2012) Thiago Roberto Lima Romero et al.   LIFE SCIENCES

Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects

(2012) Eva de Lago et al.   NEUROPHARMACOLOGY

An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo-controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain

(2012) Cory Toth et al.   PAIN

A Randomized, Controlled Trial of Gabapentin Enacarbil in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy

(2012) Richard Rauck et al.   Pain Practice

Dose related efficacy of gabapentin in acute herpetic neuralgia among geriatric patients

(2012) SanjayKumar Kanodia et al.   INDIAN JOURNAL OF DERMATOLOGY

The nature and course of sensory changes following spinal cord injury: predictive properties and implications on the mechanism of central pain

(2011) Gabi Zeilig et al.   BRAIN

Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials

(2011) Mary E. Lynch et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Neuroprotective agents: Cannabinoids

(2011) A.J. Sánchez et al.   CLINICAL IMMUNOLOGY

Role of Cannabinoids in Multiple Sclerosis

(2011) John P. Zajicek et al.   CNS DRUGS

Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy

(2011) V. Spallone et al.   DIABETIC MEDICINE

A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)

(2011) W Notcutt et al.   Multiple Sclerosis Journal

Preoperative Gabapentin for Acute Post-thoracotomy Analgesia: A Randomized, Double-Blinded, Active Placebo-Controlled Study

(2011) Michelle A. O. Kinney et al.   Pain Practice

The abuse potential of the synthetic cannabinoid nabilone

(2010) Mark A. Ware et al.   ADDICTION

Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran

(2010) Michael E. Geisser et al.   PAIN

NeuPSIG guidelines on neuropathic pain assessment

(2010) Maija Haanpää et al.   PAIN

An Open-Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy

(2010) Jennifer A. Bestard et al.   Pain Practice

Treatment of Neuropathic Pain: An Overview of Recent Guidelines

(2009) Alec B. O'Connor et al.   AMERICAN JOURNAL OF MEDICINE

Examining the roles of cannabinoids in pain and other therapeutic indications: a review

(2009) Dana Turcotte et al.   EXPERT OPINION ON PHARMACOTHERAPY

Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial

(2009) Ian Gilron et al.   LANCET

Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia

(2009) M. Melanson et al.   Multiple Sclerosis Journal

A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules

(2008) L. Mestre et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Nabilone for the Treatment of Pain in Fibromyalgia

(2007) Ryan Quinlan Skrabek et al.   JOURNAL OF PAIN